Somatostatin receptors in meningiomas: A scintigraphic study using 111In-DTPA-D-Phe-1- octreotide

C. L. Maini, A. Tofani, R. Sciuto, C. Carapella, R. Cioffi, M. Crecco

Research output: Contribution to journalArticlepeer-review

Abstract

111In-octreotide (Octreoscan) planar scintigraphy was performed in 12 patients with suspected meningioma. The scan was positive in 10 patients with meningioma and negative in two patients with acoustic neurinoma assisting in the differential diagnosis. Good quality images were obtained as early as 2h after injection and there was no increase in diagnostic quality at 24 h. No adverse effects were observed to radiopharmaceutical administration. The following conclusions are drawm: mln-octreotide is a safe and fast test which can increase the specificity of traditional neuroimaging procedures.

Original languageEnglish
Pages (from-to)550-558
Number of pages9
JournalNuclear Medicine Communications
Volume14
Issue number7
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Fingerprint Dive into the research topics of 'Somatostatin receptors in meningiomas: A scintigraphic study using <sup>111</sup>In-DTPA-D-Phe-1- octreotide'. Together they form a unique fingerprint.

Cite this